Patient info Open main menu

Zomig Rapimelt 5 mg orodispersible tablets – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
5 mg
Contains active substance:

Patient leaflet - Zomig Rapimelt 5 mg orodispersible tablets

1. What Zomig Rapimelt is and what it is used for 2. What you need to know before you take

Zomig Rapimelt

  1. 3. How to take Zomig Rapimelt
  2. 4. Possible side effects
  3. 5. How to store Zomig Rapimelt
  4. 6. Contents of the pack and other information
  5. 1. What Zomig Rapimelt is and what it is used for

Zomig Rapimelt contains zolmitriptan and belongs to a group of medicines called triptans.

Zomig Rapimelt is used to treat migraine headache.

  • Migraine symptoms may be caused by

    swollen blood vessels in the head. Zomig Rapimelt is thought to reduce the widening of these blood vessels. This helps to take away the headache and other symptoms of a migraine attack, such as feeling or being sick (nausea or vomiting) and being sensitive to light and sound.

  • Zomig Rapimelt works only when a

    migraine attack has started. It will not stop you from getting an attack.

2. What you need to know before you take Zomig Rapimelt

Do not take Zomig Rapimelt:

  • If you are allergic to zolmitriptan or any of

    the other ingredients of this medicine (listed in Section 6).

  • If you have high blood pressure.
  • If you have ever had heart problems, including

    a heart attack, angina (chest pain caused by exercise or effort), Prinzmetal’s angina (chest pain which happens at rest) or have experienced heart related symptoms such as shortness of breath or pressure over the chest. • If you have had a stroke or short-lasting

    symptoms similar to stroke (transient ischaemic attack or TIA).

  • If you are at the same time taking some other

    medicines for migraine (e.g. ergotamine or ergot-type medicines like dihydroergotamine and methysergide) or other triptan medicines for migraine. See ‘Other medicines and Zomig Rapimelt’ for further information.

Do not take Zomig Rapimelt if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before taking Zomig Rapimelt.

Warnings and precautions

Talk to your doctor of pharmacist before taking Zomig Rapimelt:

  • If you are at risk of getting ischaemic heart

    disease (poor blood flow in the arteries of the heart). Your risk is greater if you smoke, have high blood pressure, high levels of cholesterol, diabetes or if anyone in your family has ischaemic heart disease. • If you have been told that you have

    Wolff-Parkinson-White Syndrome (a type of abnormal heart beat).

  • If you have ever had liver problems. • If you have headaches which are not like

    your usual migraine headache.

  • If you are taking any medicine for treatment

    of depression (see ‘Other medicines and Zomig Rapimelt’ for further information).

If you go into hospital tell the medical staff you are taking Zomig Rapimelt.

Zomig Rapimelt is not recommended for people aged over 65.

As with other migraine treatments, using too much Zomig Rapimelt can cause daily headaches or can make your migraine headaches worse. Ask your doctor if you think that this is the case for you. You may need to stop taking Zomig Rapimelt to correct the problem.

Children and adolescents

Zomig Rapimelt is not recommended in children and adolescents under 18 years.

Other medicines and Zomig Rapimelt

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This includes herbal medicines and medicines you buy without prescription.

In particular, tell your doctor if you are taking any of the following medicines:

Medicines for migraine

  • If you take a triptan other than Zomig

    Rapimelt (such as sumatriptan or naratriptan) leave 24 hours before taking Zomig Rapimelt. • After taking Zomig Rapimelt leave 24 hours before taking another triptan.

  • If you take medicines containing ergotamine or ergot-type medicines (such as dihydroergotamine or methysergide), leave 24 hours before taking Zomig Rapimelt. • After taking Zomig Rapimelt leave 6 hours before taking ergotamine or ergot-type medicines.

Medicines for depression

  • Mono-Amine Oxidase Inhibitors, also known as MAOIs (such as moclobemide). • SSRIs (selective serotonin reuptake inhibitors) such as fluoxetine, paroxetine, fluvoxamine or sertraline.
  • SNRIs (serotonin norepinephrine reuptake inhibitors) such as venlafaxine or duloxetine. Serotonin syndrome is a rare, life-threatening condition that has been reported in some patients who took Zomig in combination with so called serotoninergic medicines (e.g. certain medicines for the treatment of depression). Signs of serotonin syndrome may be for example agitation, restlessness, fever, excessive sweating, tremor, uncoordinated movement of limbs or eyes, uncontrollable jerking of muscles, twitching and muscle rigidity. Your doctor may advise you on this.

Other medicines

  • Cimetidine (for indigestion or stomach ulcers).
  • A quinolone antibiotic (such as ciprofloxacin).

You should not take the herbal remedy St. John’s wort (Hypericum perforatum) at the same time as this medicine. If you already take a St. John’s wort preparation, stop taking it and mention this to your doctor at your next visit.

Zomig Rapimelt with food and drink

You can take Zomig Rapimelt with or without food. It does not affect the way that Zomig Rapimelt works.

Pregnancy, breast-feeding and fertility

It is not known if taking Zomig Rapimelt during pregnancy is harmful. If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Driving and using machines

During a migraine attack your reactions may be slower than usual. Bear this in mind when you drive or use any tools or machines. Zomig Rapimelt is unlikely to affect driving or using tools or machines. However, it may make you feel sleepy. Wait to see how Zomig Rapimelt affects you before you try these activities.

Zomig Rapimelt contains Aspartame (E951)

Zomig Rapimelt 5 mg orodispersible tablets contains 10 mg aspartame per tablet. Aspartame is a source of phenylalanine. It may be harmful if you have phenylketonuria (PKU), a rare genetic disorder in which phenylalanine builds up because the body cannot remove it properly.

Zomig Rapimelt contains sodium

This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium-free’.

Zomig Rapimelt contains benzyl alcohol

Zomig Rapimelt 5 mg contains 0.0000064 mg of benzyl alcohol in each orodispersible tablet. Benzyl alcohol may cause allergic reactions. Ask your doctor or pharmacist for advice if you are pregnant or breast-feeding. This is because large amounts of benzyl alcohol can build up in your body and may cause side effects (called “metabolic acidosis”).

BLACK ........... 2/29
Date/Version

Material No.

TEMP-07456
CMO Mat. No.-972
Customer Mat. No.-

15.05.2024 V3

Braille No.

-

Previous Mat. No.93040741

Colors &

Collating Marks

Class. No.50/120/23
Product NameIST.ZOMIG 5MG OROD. A6 GBR.PIEG.
9 pt

150x480 mm

(perforated to 150 x 240 mm) - single folded

Grain Direction480 mm

2-29 TEMP-07456 Ask your doctor or pharmacist for advice if you have a liver or kidney disease. This is because large amounts of benzyl alcohol can build up in your body and may cause side effects (called “metabolic acidosis”).

3. How to take Zomig Rapimelt

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. You can take this medicine as soon as a migraine headache starts. You can also take it once an attack is underway.

  • The recommended dose is one tablet (5 mg). • Peel the blister pack open as shown on the

    foil. Do not push the tablet through the foil. • Place the tablet on your tongue, where it

    will dissolve and be swallowed with the saliva. You do not have to take a drink of water in order to swallow your tablet. • You can take another tablet if the migraine

    is still present after two hours or if it returns within 24 hours.

If the tablets did not give you enough help with your migraine, tell your doctor. Your doctor may change your treatment.

Do not use more than the dose prescribed for you.

  • Do not use more than two doses in one day. • The maximum daily dose is 10 mg.

If you take more Zomig Rapimelt than you should

If you have taken more Zomig Rapimelt than prescribed by your doctor, talk to your doctor or pharmacist straight away or go to the nearest hospital straight away. Take this medicine with you.

If you forget to take Zomig Rapimelt

Do not take a double dose to make up for a forgotten dose.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. Some of the symptoms below could be part of the migraine attack itself.

If you notice any of the following serious side effects, stop taking Zomig Rapimelt and contact a doctor straight away: Rare (may affect up to 1 in 1,000 people):

  • Allergic reactions including itchy rash

    (urticaria) and swelling of the face, lips, mouth, tongue and throat.

Very rare (may affect up to 1 in 10,000 people):

  • Angina (pain in the chest, often brought on

    by exercise), heart attack or spasm of the blood vessels of the heart. The signs include chest pain and shortness of breath. • Spasm of the blood vessels of the gut, which

    can cause damage to your gut. The signs include stomach pain or bloody diarrhoea. • Bleeding in the brain (cerebral bleeding) or

    stroke.

Other possible side effects include: Common (may affect up to 1 in 10 people):

These side effects are usually mild and go away after a short time.

  • Abnormal sensations such as tingling in

    your fingers and toes or skin that is sensitive to touch.

  • Feeling sleepy, dizzy or warm.
  • Headache.
  • Uneven heart beat.
  • Feeling sick (nausea) or being sick (vomiting). • Stomach pain.
  • Dry mouth.
  • Muscle weakness or muscle pain. • Feeling weak.
  • Heaviness, tightness, pain or pressure in

    the throat, neck, arms and legs, or chest. • Problems swallowing.

Uncommon (may affect up to 1 in 100 people):

  • Very fast heart beat.
  • Slightly higher blood pressure.
  • Increase in the amount of water you pass

    (urine) or in how often you need to pass water.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Zomig Rapimelt

  • Keep this medicine out of the sight and reach of children.
  • Keep your medicine in the container it came in.
  • Do not use this medicine after the expiry date stated on the carton. The expiry date refers to the last day of that month. • Do not store above 25°C.
  • Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Zomig Rapimelt 5 mg orodispersible tablet contains

The active ingredient is zolmitriptan. Each tablet contains 5 mg of zolmitriptan.

The other ingredients are: aspartame (E951), citric acid anhydrous, silica colloidal anhydrous, crospovidone, magnesium stearate, mannitol (E421), microcrystalline cellulose, orange flavour (contains benzyl alcohol) and sodium hydrogen carbonate.

What Zomig Rapimelt 5 mg orodispersible tablets look like and contents of the pack

  • Zomig Rapimelt 5 mg orodispersible tablets are white, flat-faced, round and marked with ‘Z 5’ on one side.
  • Zomig Rapimelt 5 mg orodispersible tablets come in peelable aluminium laminate blister packs containing 6 tablets.

Zomig may also be available as orodispersible 2.5 mg tablets, nasal spray 5 mg/dose and film-coated tablets 2.5 mg.

Marketing Authorisation Holder and Manufacturer

The Marketing Authorisation for Zomig Rapimelt 5 mg orodispersible tablets is held by Grünenthal Ltd,

TOR Building,

Saint Cloud Way,

Maidenhead,

Berkshire, SL6 8BN,

United Kingdom.

Zomig Rapimelt 5 mg orodispersible tablets are manufactured by

Farmaceutici Formenti S.p.A.

Via Di Vittorio 2,

21040 Origgio (VA)

Italy

To listen to or request a copy of this leaflet in Braille, large print or audio please call, free of charge:

0800 198 5000 (UK only) Please be ready to give the following information: Product name Zomig Rapimelt 5 mg

Reference number PL 21727/0084

This is a service provided by the Royal National Institute of Blind People.

This leaflet was last revised in:

May 2024

BLACK ........... 2/29
Date/Version

Material No.

TEMP-07456
CMO Mat. No.-972
Customer Mat. No.-

15.05.2024 V3

Braille No.

-

Previous Mat. No.93040741

50/120/23

IST.ZOMIG 5MG OROD. A6 GBR.PIEG.

9 pt

Colors &

Collating Marks

Class. No.
Product Name

150x480 mm

(perforated to 150 x 240 mm) - single folded

Grain Direction480 mm

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 21727/0084

Last revision stated in the text: May 2024 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Zomig Rapimelt 5 mg orodispersible tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Zolmitriptan
Strength 5 mg
Pharmaceutical form Orodispersible tablet
How is it taken Oral
Excipients Aspartame (E951), Citric Acid Anhydrous, Silica Colloidal Anhydrous, Crospovidone, Magnesium stearate, Mannitol (E421), Microcrystalline Cellulose, Orange Flavour (contains benzyl alcohol), Sodium Hydrogen Carbonate
Pack sizes 6 tablet
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 2 years
Storage Do not store above 25°C.
Drug group (ATC) Selective serotonin (5HT1) agonists
  1. N Nervous system drugs
    1. N02 Analgesics
      1. N02C Antimigraine preparations
        1. N02CC Selective serotonin (5HT1) agonists, antimigraine drugs
          1. N02CC03 zolmitriptan
Marketing authorisation PL 21727/0084 (first authorised 21 September 2004)
Marketing authorisation holder Grünenthal Limited
Codes GTIN 4032129076303 · BNF 04070401

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.